Interpace Biosciences, Inc. (IDXG) stock
IDXGOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/30
$5.00−0.15 (-2.91%)
Close on Oct 19, 2026Market cap $138.57MP/E 5.6Yield –
Interpace Biosciences cash
Cash and short-term investments held at the end of each period.
Interpace Biosciences's cash was $2.69M at Jun 30, 2026. For fiscal 2025 it was $2.51M, up 71.5% from the year before. Over ten years it grew -11.4% a year on average. The highest annual figure on record is $72.46M in fiscal 2009.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.51M | +71.5% |
| FY2024 | Dec 31, 2024 | $1.46M | -58.2% |
| FY2023 | Dec 31, 2023 | $3.50M | -27.5% |
| FY2022 | Dec 31, 2022 | $4.83M | +45.7% |
| FY2021 | Dec 31, 2021 | $3.31M | -1.7% |
| FY2020 | Dec 31, 2020 | $3.37M | +45.3% |
| FY2019 | Dec 31, 2019 | $2.32M | -61.8% |
| FY2018 | Dec 31, 2018 | $6.07M | -60.1% |
| FY2017 | Dec 31, 2017 | $15.20M | +2424.8% |
| FY2016 | Dec 31, 2016 | $602.00K | -92.8% |
| FY2015 | Dec 31, 2015 | $8.42M | -63.8% |
| FY2014 | Dec 31, 2014 | $23.22M | -49.2% |
| FY2013 | Dec 31, 2013 | $45.74M | -13.5% |
| FY2012 | Dec 31, 2012 | $52.88M | -18.0% |
| FY2011 | Dec 31, 2011 | $64.46M | +2.6% |
| FY2010 | Dec 31, 2010 | $62.86M | -13.3% |
| FY2009 | Dec 31, 2009 | $72.46M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $2.69M | +435.5% |
| Q1 FY2026 | Mar 31, 2026 | $2.65M | +121.3% |
| Q4 FY2025 | Dec 31, 2025 | $2.51M | +71.5% |
| Q3 FY2025 | Sep 30, 2025 | $1.42M | +1.6% |
| Q2 FY2025 | Jun 30, 2025 | $502.00K | +0.4% |
| Q1 FY2025 | Mar 31, 2025 | $1.20M | -57.5% |
| Q4 FY2024 | Dec 31, 2024 | $1.46M | -58.2% |
| Q3 FY2024 | Sep 30, 2024 | $1.40M | -72.2% |
| Q2 FY2024 | Jun 30, 2024 | $500.00K | -90.2% |
| Q1 FY2024 | Mar 31, 2024 | $2.81M | -49.7% |
| Q4 FY2023 | Dec 31, 2023 | $3.50M | -27.5% |
| Q3 FY2023 | Sep 30, 2023 | $5.03M | -20.2% |
| Q2 FY2023 | Jun 30, 2023 | $5.08M | +140.1% |
| Q1 FY2023 | Mar 31, 2023 | $5.60M | +80.5% |
| Q4 FY2022 | Dec 31, 2022 | $4.83M | +45.7% |
| Q3 FY2022 | Sep 30, 2022 | $6.31M | +83.9% |
| Q2 FY2022 | Jun 30, 2022 | $2.12M | -44.2% |
| Q1 FY2022 | Mar 31, 2022 | $3.10M | +9.2% |
| Q4 FY2021 | Dec 31, 2021 | $3.31M | -1.7% |
| Q3 FY2021 | Sep 30, 2021 | $3.43M | -35.4% |
| Q2 FY2021 | Jun 30, 2021 | $3.79M | -74.9% |
| Q1 FY2021 | Mar 31, 2021 | $2.84M | -78.8% |
| Q4 FY2020 | Dec 31, 2020 | $3.37M | +45.3% |
| Q3 FY2020 | Sep 30, 2020 | $5.31M | +125.1% |
| Q2 FY2020 | Jun 30, 2020 | $15.11M | +258.8% |
| Q1 FY2020 | Mar 31, 2020 | $13.37M | +46.5% |
| Q4 FY2019 | Dec 31, 2019 | $2.32M | -61.8% |
| Q3 FY2019 | Sep 30, 2019 | $2.36M | -70.5% |
| Q2 FY2019 | Jun 30, 2019 | $4.21M | -58.3% |
| Q1 FY2019 | Mar 31, 2019 | $9.12M | -27.8% |
| Q4 FY2018 | Dec 31, 2018 | $6.07M | -60.1% |
| Q3 FY2018 | Sep 30, 2018 | $8.00M | -31.6% |
| Q2 FY2018 | Jun 30, 2018 | $10.08M | -29.3% |
| Q1 FY2018 | Mar 31, 2018 | $12.65M | +77.4% |
| Q4 FY2017 | Dec 31, 2017 | $15.20M | +2424.8% |
| Q3 FY2017 | Sep 30, 2017 | $11.70M | +591.3% |
| Q2 FY2017 | Jun 30, 2017 | $14.27M | – |
| Q1 FY2017 | Mar 31, 2017 | $7.13M | – |
| Q4 FY2016 | Dec 31, 2016 | $602.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $1.69M | – |
See a number that looks wrong?